Movano Inc (MOVE) - Net Assets
Based on the latest financial reports, Movano Inc (MOVE) has net assets worth $-1.70 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.56 Million) and total liabilities ($7.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Movano Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.70 Million |
| % of Total Assets | -30.61% |
| Annual Growth Rate | -16.95% |
| 5-Year Change | N/A |
| 10-Year Change | -94.39% |
| Growth Volatility | 3891.99 |
Movano Inc - Net Assets Trend (2000–2024)
This chart illustrates how Movano Inc's net assets have evolved over time, based on quarterly financial data. Also explore MOVE asset base for the complete picture of this company's asset base.
Annual Net Assets for Movano Inc (2000–2024)
The table below shows the annual net assets of Movano Inc from 2000 to 2024. For live valuation and market cap data, see Movano Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $7.36 Million | +113.25% |
| 2023-12-31 | $3.45 Million | -56.42% |
| 2022-12-31 | $7.92 Million | -75.82% |
| 2021-12-31 | $32.73 Million | +505.98% |
| 2020-12-31 | $-8.06 Million | -301.70% |
| 2019-12-31 | $4.00 Million | +32.61% |
| 2018-12-31 | $3.01 Million | -97.23% |
| 2013-12-31 | $108.83 Million | +11.04% |
| 2012-12-31 | $98.01 Million | -25.31% |
| 2011-12-31 | $131.22 Million | -34.17% |
| 2010-12-31 | $199.34 Million | +7.32% |
| 2009-12-31 | $185.74 Million | +6.66% |
| 2008-12-31 | $174.14 Million | -15.33% |
| 2007-12-31 | $205.67 Million | +4.05% |
| 2006-12-31 | $197.66 Million | +28.96% |
| 2005-12-31 | $153.27 Million | +167.06% |
| 2004-12-31 | $57.39 Million | +17397.87% |
| 2003-12-31 | $328.00K | -99.15% |
| 2002-12-31 | $38.73 Million | -78.87% |
| 2001-12-31 | $183.26 Million | -71.11% |
| 2000-12-31 | $634.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Movano Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14810700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.00K | 0.14% |
| Other Components | $155.45 Million | 2113.56% |
| Total Equity | $7.36 Million | 100.00% |
Movano Inc Competitors by Market Cap
The table below lists competitors of Movano Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Solartron Public Company Limited
BK:SOLAR
|
$13.44 Million |
|
Ep&T Global Ltd
AU:EPX
|
$13.44 Million |
|
Scidev Ltd
AU:SDV
|
$13.45 Million |
|
Adriatic Metals
LSE:ADT1
|
$13.45 Million |
|
Glennon Small Companies Ltd
AU:GC1
|
$13.44 Million |
|
NETUM GROUP OYJ
F:79J
|
$13.44 Million |
|
Nuvotec
KQ:060260
|
$13.44 Million |
|
TJGC Group Limited
NASDAQ:TJGC
|
$13.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Movano Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,449,000 to 7,355,000, a change of 3,906,000 (113.3%).
- Net loss of 23,727,000 reduced equity.
- New share issuances of 24,325,000 increased equity.
- Other factors increased equity by 3,308,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-23.73 Million | -322.6% |
| Share Issuances | $24.32 Million | +330.73% |
| Other Changes | $3.31 Million | +44.98% |
| Total Change | $- | 113.25% |
Book Value vs Market Value Analysis
This analysis compares Movano Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 120.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 156.79x to 120.47x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $0.09 | $14.71 | x |
| 2019-12-31 | $0.12 | $14.71 | x |
| 2020-12-31 | $-0.25 | $14.71 | x |
| 2021-12-31 | $1.00 | $14.71 | x |
| 2022-12-31 | $0.24 | $14.71 | x |
| 2023-12-31 | $0.07 | $14.71 | x |
| 2024-12-31 | $0.12 | $14.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Movano Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -322.60%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2342.25%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 1.54x
- Recent ROE (-322.60%) is below the historical average (-148.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.36% | 0.22% | 1.01x | 1.62x | $-14.78 Million |
| 2006 | 11.18% | 7.61% | 1.02x | 1.45x | $2.34 Million |
| 2007 | 0.48% | 0.34% | 1.01x | 1.37x | $-19.59 Million |
| 2011 | 5.53% | 3.79% | 1.16x | 1.26x | $-5.86 Million |
| 2012 | 5.74% | 2.82% | 1.46x | 1.40x | $-4.18 Million |
| 2013 | 0.53% | 0.25% | 0.96x | 2.18x | $-10.31 Million |
| 2018 | -115.73% | 0.00% | 0.00x | 1.13x | $-3.79 Million |
| 2019 | -211.16% | 0.00% | 0.00x | 1.22x | $-8.84 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.23 Million |
| 2021 | -68.99% | 0.00% | 0.00x | 1.11x | $-25.86 Million |
| 2022 | -381.50% | 0.00% | 0.00x | 1.67x | $-30.99 Million |
| 2023 | -849.03% | 0.00% | 0.00x | 2.73x | $-29.63 Million |
| 2024 | -322.60% | -2342.25% | 0.09x | 1.54x | $-24.46 Million |
Industry Comparison
This section compares Movano Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Movano Inc (MOVE) | $-1.70 Million | 0.36% | N/A | $13.44 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About Movano Inc
Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period… Read more